Literature DB >> 9830201

Human African trypanosomiasis: an emerging public health crisis.

D H Smith1, J Pepin, A H Stich.   

Abstract

There is a dramatic resurgence of human African trypanosomiasis (HAT) in sub-Saharan Africa. T.b. gambiense is spreading epidemically in large areas of Central Africa, especially the Southern Sudan, Congo-Zaire, Angola, Uganda and the Central African Republic. Devastating epidemics of T.b. rhodesiense have occurred in south-eastern Uganda. The causes of the re-emergence of sleeping sickness as a public health problem include widespread civil disturbance and war, declining economies, reduced health financing and the dismantling of disease control programmes. Despite the inevitably fatal outcome without treatment, HAT is often given low priority by donors and national governments. The advances made in diagnosis, treatment and vector control have not been sufficiently implemented. To limit the human impact in some of the poorest communities in Africa, endemic countries will require external support to implement strategies for disease control. Donor agencies, NGOs and mission organisations could play an important role in supporting control efforts. National authorities will need to control and co-ordinate these efforts with assistance from WHO and the international community.

Entities:  

Mesh:

Year:  1998        PMID: 9830201     DOI: 10.1093/oxfordjournals.bmb.a011692

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  37 in total

1.  Antitrypanosomal activity of fluoroquinolones.

Authors:  E Nenortas; C Burri; T A Shapiro
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers.

Authors:  Mihaela Lorger; Markus Engstler; Matthias Homann; H Ulrich Göringer
Journal:  Eukaryot Cell       Date:  2003-02

3.  Analysis of a donor gene region for a variant surface glycoprotein and its expression site in African trypanosomes.

Authors:  D J LaCount; N M El-Sayed; S Kaul; D Wanless; C M Turner; J E Donelson
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

4.  The DNA sequence of chromosome I of an African trypanosome: gene content, chromosome organisation, recombination and polymorphism.

Authors:  Neil Hall; Matthew Berriman; Nicola J Lennard; Barbara R Harris; Christiane Hertz-Fowler; Emmanuelle N Bart-Delabesse; Caroline S Gerrard; Rebecca J Atkin; Andrew J Barron; Sharen Bowman; Sarah P Bray-Allen; Frédéric Bringaud; Louise N Clark; Craig H Corton; Ann Cronin; Robert Davies; Jonathon Doggett; Audrey Fraser; Eric Grüter; Sarah Hall; A David Harper; Mike P Kay; Vanessa Leech; Rebecca Mayes; Claire Price; Michael A Quail; Ester Rabbinowitsch; Christopher Reitter; Kim Rutherford; Jürgen Sasse; Sarah Sharp; Ratna Shownkeen; Annette MacLeod; Sonya Taylor; Alison Tweedie; C Michael R Turner; Andrew Tait; Keith Gull; Bart Barrell; Sara E Melville
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

Review 5.  Human African trypanosomiasis.

Authors:  August Stich; Paulo M Abel; Sanjeev Krishna
Journal:  BMJ       Date:  2002-07-27

Review 6.  Tsetse genetics: contributions to biology, systematics, and control of tsetse flies.

Authors:  R H Gooding; E S Krafsur
Journal:  Annu Rev Entomol       Date:  2005       Impact factor: 19.686

7.  Methionine regeneration and aspartate aminotransferase in parasitic protozoa.

Authors:  L C Berger; J Wilson; P Wood; B J Berger
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

8.  Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.

Authors:  A M Aronov; S Suresh; F S Buckner; W C Van Voorhis; C L Verlinde; F R Opperdoes; W G Hol; M H Gelb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

9.  Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic.

Authors:  Alice I Goumba; Xavier Konamna; Narcisse P Komas
Journal:  BMC Infect Dis       Date:  2011-04-14       Impact factor: 3.090

10.  Antitrypanosomal activities of fluoroquinolones with pyrrolidinyl substitutions.

Authors:  Elizabeth Nenortas; Tomasz Kulikowicz; Christian Burri; Theresa A Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.